Predicting the effects of drugs that modulate calcium transients
Disopyramide Disopyramide, classified as a type I antiarrhythmic (i.e., a sodium channel blocker) is a potent negative i…
04 January, 2023Developed over 18 years and critically acclaimed in over 60 peer-reviewed journals, our MUSICO Platform consists of multiple submodules for simulating a wide variety of experiments from molecular kinetics to whole organ simulations.
With this set of industry-leading tools (groundbreaking, state-of-the-art) we can help you expedite and reduce the cost and number of experiments for your muscle research, drug discovery, or create better-personalized treatment strategies.
Disopyramide Disopyramide, classified as a type I antiarrhythmic (i.e., a sodium channel blocker) is a potent negative i…
04 January, 2023Multiscale modeling of left ventricle In silico clinical trials are the future of medicine and virtual testing and simul…
02 January, 2023Effect of Myosin Isoforms from Mouse to Human To understand how pathology-induced changes in contractile protein isoform…
02 January, 2023Multiscale Computational modeling
Designing and conducting experiments (in solution, in motility assays, in muscle fibers, in tissues, X-ray diffraction)
Data analysis
Guidance in Drug development
Developing new strategies for effective treatment of myopathies
Human cardiac mutations in database
Research partners
Peer-reviewed publications
Years of platform development
Illinois Institute of Technology
– www.iit.edu